Travere Therapeutics, Inc. TVTX
NASDAQ · United States · Health Technology
$57.14-1.74 (-2.96%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.37 | -0.13 | -174.8% | $169.58M | +7.8% | +14.2%$54.98→$62.76 |
| Q1 2026 | 2026-05-04 | 0.05 | -0.06 | +183.3% | — | — | +1.5%$44.12→$44.80 |
| Q4 2025 | 2026-02-19 | 0.37 | 0.37 | 0.0% | — | — | +9.0%$27.87→$30.39 |
| Q3 2025 | 2025-10-30 | 0.28 | -0.31 | +190.3% | — | — | +17.3%$29.98→$35.16 |
| Q4 2024 | 2025-02-20 | -0.47 | -0.38 | -23.7% | — | — | — |
| Q3 2024 | 2024-10-31 | -0.46 | -0.54 | +14.8% | — | — | — |
| Q1 2024 | 2024-05-06 | -1.51 | -0.79 | -91.1% | — | — | — |
| Q4 2023 | 2024-02-15 | -0.94 | -0.92 | -2.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.